Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer

Respirology

Volumn 11, Issue 1, 2006, Pages 90-97

  Ishida, Atsuko ^a,d   Miyazawa, Teruomi ^a,d   Miyazu, Yuka ^a,d   Iwamoto, Yasuo ^a   Zaima, Mika ^a   Kanoh, Koji ^b   Sumiyoshi, Hidetaka ^c   Doi, Masao ^c  

^a HIROSHIMA CITY HOSPITAL   (Japan)

^b Fukushima Co op Hospital   (Japan)

^c HIROSHIMA PREFECTURAL HOSPITAL   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Intrapleural chemotherapy; Malignant pleural effusion; OK432; Pleurodesis

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; PICIBANIL; SCLEROSING AGENT;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG FEVER; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; MONOTHERAPY; MORTALITY; NAUSEA; PLEURA EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; THORAX DRAINAGE; THORAX PAIN; TUBE;

AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PICIBANIL; PLEURAL EFFUSION, MALIGNANT; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33645109670     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00790.x     Document Type: Article

References (36)

1. Antony VB Loddenkemper R Astoul P et al. Management of malignant pleural effusions EurRespirJ 2001 18 402 19
2. Sahn SA Management of malignant pleural effusions Monaldi ArchChest Dis 2001 56 394 9
3. Reeder LB Malignant pleural effusions CurrTreatOptions Oncol 2001 2 93 6
4. Johnston WW The malignant pleural effusion: a review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients Cancer 1985 56 905 9
5. Livingston RB McCracken JD Trauth CJ Chen T Isolated pleural effusion in small cell lung carcinoma: favorable prognosis Chest 1982 81 208 11
6. Marchi E Teixeira LR Vargas FS Management of malignancy-associated pleural effusion: current and future treatment strategies AmJRespirMed 2003 2 261 73
7. Walker-Renard PB Vaughan LM Sahn SA Chemical pleurodesis for malignant pleural effusions AnnInternMed 1994 120 56 64
8. Grossi F Pennucci MC Tixi L Cafferata MA Ardizzoni A Management of malignant pleural effusions Drugs 1998 55 47 58
9. Diacon AH Wyser C Bolliger CT et al. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions AmJRespirCritCare Med 2000 162 1445 9
10. Read CA Wohlrab JL Szwed TW Anderson ED Thoracoscopy with talc pleurodesis shortens hospitalization JBronchol 2002 9 281 5
11. Hartman DL Gaither JM Kesler KA Mylet DM Brown JW Mathur PN Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions JThoracCardiovascSurg 1993 105 743 8
12. Fentiman IS Rubens RD Hayward JL A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer EurJCancer ClinOncol 1986 22 1079 81
13. Sanchez-Armengol A Rodriguez-Panadero F Survival and talc pleurodesis in metastatic pleural carcinoma, revisited: report of 125 cases Chest 1993 104 1482 5
14. Lee YC Baumann MH Maskell NA et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists Chest 2003 124 2229 38
15. Kataoka M Morishita R Hiramatsu J et al. OK-432 induces production of neutrophil chemotactic factors in malignant pleural effusion InternMed 1995 34 352 6
16. Luh KT Yang PC Kuo SH Chang DB Yu CJ Lee LN Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer: a randomized trial Cancer 1992 69 674 9
17. Masuno T Kishimoto S Ogura T et al. A comparative trial of LC9018 plus doxorubicin and doxorubicin alone for the treatment of malignant pleural effusion secondary to lung cancer Cancer 1991 68 1495 500
18. Rusch VW Figlin R Godwin D Piantadosi S Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial JClinOncol 1991 9 313 19
19. Aziz T Jilaihawi A Prakash D The management of malignant pleural mesothelioma; single centre experience in 10 years EurJCardiothoracSurg 2002 22 298 305
20. Tohda Y Iwanaga T Takada M et al. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer Chemotherapy 1999 45 197 204
21. Shoji T Tanaka F Yanagihara K Inui K Wada H Phase II study of repeated intrapleural chemotherapy using implantable access system for management of malignant pleural effusion Chest 2002 121 821 4
22. Los G Mutsaers PH van der Vijgh WJ Baldew GS de Graaf PW McVie JG Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy Cancer Res 1989 49 3380 4
23. Fujino T Deguchi H Kawakami M et al. Two cases of non-small cell lung cancer with pleural effusion showing good responses to intrapleural administration of carboplatin and OK-432 Nissay HospMedJ 1997 25 55 8 (in Japanese, abstract in English).
24. Kishi K Kawabata M Tsuboi N et al. Pleurodesis with a combination of OK-432 and adriamycin for malignant pleural effusions caused by lung cancer Jpn JLung Cancer 1999 39 261 6 (in Japanese, abstract in English).
25. Ernst A Hersh CP Herth F et al. A novel instrument for the evaluation of the pleural space: an experience in 34 patients Chest 2002 122 1530 4
26. Ishida A Iwamoto Y Miyazu Y Miyazawa T Diagnosis of tuberculous pleurisy using a flexirigid thoracoscope JBronchol 2004 11 29 31
27. Kawano M Miura H Anan H Shimizu M Treatment of secondary spontaneous pneumothorax complicating silicosis and progressive massive fibrosis Kurume MedJ 2002 49 35 40
28. Shimizu J Hayashi Y Oda M et al. Treatment of postoperative chylothorax by pleurodesis with the streptococcal preparation OK-432 ThoracCardiovascSurg 1994 42 233 6
29. Antunes G Neville E Duffy J Ali N Pleural Disease Group Standards of Care Committee, British Thoracic Society. BTS guidelines for the management of malignant pleural effusions Thorax 2003 58 Suppl. 2 ii29 38
30. Su WC Lai WW Chen HH et al. Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion: a pilot study Oncology 2003 64 18 24
31. Monjanel-Mouterde S Frenay C Catalin J Boutin C Durand A Astoul P Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions OncolRep 2000 7 171 5
32. Rinaldo JE Owens GR Rogers RM Adult respiratory distress syndrome following intrapleural instillation of talc JThoracCardiovascSurg 1983 85 523 6
33. Rehse DH Aye RW Florence MG Respiratory failure following talc pleurodesis AmJSurg 1999 177 437 40
34. Light RW Talc for pleurodesis? Chest 2002 122 1506 8
35. Fraticelli A Robaglia-Schlupp A Riera H Monjanel-Mousterde S Cau P Astoul P Distribution of calibrated talc after intrapleural administration: an experimental study in rats Chest 2002 122 1737 41
36. Maskell NA Lee YC Gleeson FV Hedley EL Pengelly G Davies RJ Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size AmJRespirCritCare Med 2004 170 377 82